education: positionsen.pasteur.ac.ir/userfiles/file/cv/clinical research epidemiology... · occult...

1

Curriculum Vitae

Name: Arezoo Aghakhani

Address: Clinical Research Department, Pasteur Institute of Iran (IPI), No. 69, Pasteur

Ave., Tehran 1316943551, Iran

Tel: (+98-21) 64112808

Fax: (+98-21) 64112812

E-mail: [email protected]

[email protected]

Education:

1997-2001 Pathology Specialty (Anatomical & Clinical): Shahid Beheshti

University of Medical Sciences, Tehran, Iran.

1989-1996 MD: Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Positions:

• Academic Member: Department of Clinical research and Electron

Microscopy, Pasteur Institute of Iran, Tehran, Iran (From 2004)

• Pathologist & Researcher: Research Center of Gastroentrology and Liver

Disease, Taleghani Hospital, Shahid Beheshti University of Medical Sciences,

Tehran, Iran (2001-2003)

2

Membership:

• Member of Iranian Society of Pathology

• Member of International Academy of Pathology (IAP)

• Member of Iranian Cancer Association

• Member of Iranian Society for Support of Patients with Infectious

Diseases

• Member of European Society of Clinical Microbiology and Infectious

Diseases (ESCMID)

• Member of International Society of Infectious Diseases (ISID)

• Associated Editor and Editorial Board of Iranian Journal of Pathology

• Contributing Associate Editors-in-Chief of World Journal of

Gastroenterology

• Associated Editor and Editorial Board of Hepatitis Monthly Journal

• Regional Editor of Asian Journal of Medical Sciences

• Editorial Board of Journal of Gastroenterology and Hepatology

• Editorial Board of Journal of Therapy and Management in HIV

Infection

• Editorial Board of Global Journal of Oncologist

• Editorial Board of Case Reports in Clinical Pathology

• Editorial Board of SM Journal of Clinical Pathology

• Editorial Board of Hepatoma Research

• Editorial Board of Arak Medical University Journal

• Member of Scientific Committee of Annual Congress of

Pathology (10th

-18th

) and Annual Congress of Iranian Cancer

Association(4th

-7th

)

3

• Member of Scientific Executive Committee of Iranian Congress on

Infectious Diseases and Tropical Medicine(14th

-25th

)

• Member of Scientific Committee of the 3rd

and 4th

Annual Iranian

Congress on HIV/AIDS.

• Member of Scientific Committee of National Congress on

Brucellosis(2011)

• Member of Scientific Committee of the 11th

International Congress of

Immunology & Allergy of Iran (2012)

• Member of Scientific Committee of first International Congress of

Pathology and Laboratory Medicine (2017)

• Member of Ethics Committee of Pasteur Institute of Iran

Journal referee for:

• Journal of Medical Virology

• Journal of Clinical Virology

• Epidemiology and Infection Journal

• Antiviral Therapy Journal

• Hepatitis Monthly Journal

• World Journal of Gastroenterology

• World Journal of Hepatology

• Iranian Journal of Infectious Disease and Tropical Medicine

• Iranian Journal of Pathology

• African Journal of Microbiology Research

• Annals of Clinical Microbiology and Antimicrobials

• Indian Journal of Medical Sciences

• The Journal of Infection in Developing Countries

• Reviews in Infection

• Therapeutic Apheresis and Dialysis Journal

• Journal of Research in Medical Sciences

4

• Hemodialysis International

Teaching Course:

Electron microscopy and Pathology courses for M.Sc. and PhD students

Projects:

• Direct-acting Antivirals (DAA) Resistance-associated Variants in Treatment-

naïve HCV/HIV Co-infected and HCV Infected Patients (2016-2018)

• Frequency of occult hepatitis B virus infection among HBV-vaccinated

individuals according to national vaccination protocol (2016-2018)

• Seroepidemiological study of HBV infection and vaccine escape mutants

among individuals vaccinated with HBV vaccine (according to EPI protocol):

22 years after vaccination (2015-2018)

• Investigation of the seroepidemiology, prevalence and viral load of human

parvovirus B19 virus in blood donors in Tehran (2016-2017)

• Assessing the necessity and timing of HPV vaccination based on

seroepidemiology of human papillomavirus 16 and 18 in general population in

Tehran (2015-2017)

• The role of Herpes Simplex virus Type-2 infection in outcome of HIV-1

infected patients (2014-2017)

• Study of occult hepatitis B virus infection and its vaccine escape mutants in

HIV positive patients vaccinated with hepatitis B vaccine(2014-2016)

• Prevalence of occult Hepatitis C virus infection in kidney transplantation

candidates in Iran (2014-2016)

5

• Comparing efficacy of two strategies of HBV vaccination in HIV infected

patients (2012-2015)

• Prevalence of Parvovirus B19 Infection in Patients Infected with Human

Immunodeficiency Virus referred to Iranian research center for HIV and

AIDS(IRCHA) (2013-2014)

• Frequency of human papillomavirus infection in colon tissues of patients with

colon adenocarcinoma and adenomatous polyps referring to Shaheed Beheshti

University hospitals (2012)

• Frequency of occult Hepatitis B infection and S gene mutations in dialysis

patients (2012)

• Seroepidemiology of IgG antibodies against Diphtheria and Tetanus in blood

donors of Arak city(2012)

• Serum profile of T helper 1 and 2 cytokines in patients with chronic hepatitis

C virus infection(2011)

• Association of interleukin-10 gene promoter polymorphisms with outcome of

hepatitis B virus infection (2011)

• TH1/TH2 cytokine levels as an indicator for disease progression in human

immunodeficiency virus type 1 infected patients(2011)

• Prevalence and genotype determination of HTLV 1 & 2 in HIV positive

patients (2010-2011)

• Frequency and genotype of hepatitis D virus in high risk groups for hepatitis B

virus acquisition (2010)

• Occult hepatitis B virus infection and mutations in the S gene region in

vaccinated children(2009-2010)

6

• Seroepidemiology of IgG antibody against Bordetella pertussis in 6-20 years

age group habitant of Tehran(2009-2010)

• Frequency of human papillomavirus infection in patients with breast

carcinoma and benign breast samples referring to Shohada , Loghman and

Imam Khomeini hospitals (2009-2010)

• Seroepidemiology of antibody against Hepatitis A virus (anti-HAV) in 8

months to 20 years age group habitant of Tehran (2009)

• Frequency of occult Hepatitis B virus infection in blood donors with isolated

anti-HBc in Arak city (2009)

• Assessment of antibody levels to Hepatitis B virus surface antigen in routinely

vaccinated children via vaccination program of Iran (2009)

• Association of polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with

outcome of hepatitis B virus infection (2008-2010)

• Frequency of human papillomavirus infection in prostate tissues of patients

with prostate carcinoma and benign prostatic hyperplasia referring to Shaheed

Beheshti University hospitals (2008-2010)

• Hepatitis B virus genotyping in hepatocellular carcinoma in Iranian patients

(2006-2008)

• The effect of chronic L-arginine administration on endothelial cell apoptosis

and serum antioxidant level in high-cholesterol fed rabbits (2007)

• Frequency of Hepatitis G(HGV) in Hemodialysis and peritoneal dialysis

patients and dialysis ward staff in Imam Khomeini Hospital (2005-2006)

• The role of fungi and HLA antigens in the etiology of chronic rhino-sinusitis

in individuals admitted to the Shaheed Beheshti Medical Sciences Hospitals

(2004-2009)

7

• Prevalence of HPV16&18 in patients with esophageal carcinoma (2003-2005)

Publications:

Papers:

• Aghakhani A, Mamishi S, Sabeti S, Bidari-Zerehpoosh F, Banifazl M,

Bavand A, Ramezani A. Gender and Age-specific Seroprevalence of Human

Papillomavirus 16 and 18 in General Population in Tehran, Iran. Medical

Microbiology and Immunology (in press)

• Sharif A, Aghakhani A, Velayati A, Banifazl M, Sharif MR, Razeghi E,

Kheirkhah D, Kazemimanesh M, Bavand A and Ramezani A. Frequency and

Genotype of Human Parvovirus B19 among Iranian Hemodialysis and

Peritoneal Dialysis Patients. Intervirology (in press)

• Sofian M, Ramezani A, Mousavi A, Banifazl M, Cherei S, Cherei A and

Aghakhani A. Interlukine-17 and TGF-β Levels in Patients with Acute

Brucellosis Before and After Treatment. Turkish Journal of Medical Sciences

46(5):1348-52(2016)

• Sofian M, Ramezani A, Imani H, Farazi A, Banifazl M, Jourabchi A,

Aghakhani A. Distribution of Hepatitis C Virus Genotypes in Arak City,

Central Province of Iran. Iranian Journal of Microbiology 8(5):321-325(2016)

• Sofian M, Banifazl M, Ziai M, Aghakhani A, Farazi A, Ramezani A. Intra-

familial Transmission of Hepatitis B Virus Infection in Arak, Iran. Iranian

Journal of Pathology 11(4):328-333(2016)

• Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhan A, Bidari-

Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifaz M, Azimian-Zavareh F,

8

Motevalli F, Soleymani S and Ramezani A. Low Prevalence of Hepatitis B

Vaccine Escape Mutants among Individuals Born after the Initiation of

Nationwide Vaccination Program in Iran. Archives of Virology 161(12):3405-

3411(2016)

• Aghakhani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R,

Karami A, Foroughi M and Ramezani A. Occult Hepatitis B Virus Infection

and S Gene Escape Mutants in HIV Infected Patients after HBV Vaccination.

International Journal of STD & AIDS 27(11):967-72 (2016)

• Ramezani A, Saboori E, Azadmanesh K, Mohraz M, Kazemimanesh M,

Banifazl M, Mamishi S, Golchehregan H and Aghakhani A. No Evidence of

Human Herpesvirus 8 among Iranian Patients Infected With HIV. Iranian

Journal of Public Health 45(7):935-940(2016)

• Jozpanahi M, Ramezani A, Ossareh S, Banifazl M, Bavand A, Mamishi S,

Aghakhani A. BK Viremia among Iranian Renal Transplant Candidates.

Iranian Journal of Pathology 11(3):210-215 (2016)

• Aghakhani A, Mohraz M, Azadmanesh K, Moayedi-Nia S, Kazemimanesh

M, Mamishi S, Banifazl M, Ramezani A. No Evidence of Persistent

Parvovirus B19 Viremia among Iranian Patients with HIV after 1 Year Follow

up. Archives of Virology 161(5):1183-7(2016)

• Akhgari SH, Mohraz M, Azadmanesh K, Vahabpour R, Kazemimanesh M,

Aghakhani A, Jozpanahi M, Banifazl M, Bavand A and Ramezani A.

Frequency and Subtype of BK Virus Infection in Iranian Patients Infected with

HIV. Medical Microbiology and Immunology 205:57-62(2016)

• Eslamifar A, Ramezani A, Ehteram H, Razeghi E, Ahmadi F, Amini M,

Banifazl M, Etemadi G, Keyvani H, Bavand A and Aghakhani A.

9

Occult Hepatitis C Virus Infection in Iranian Hemodialysis Patients. Journal of

Nephropathology 4(4):116-120 (2015)

• Azadmanesh K, Mohraz M, Kazemimanesh M, Aghakhani A, Foroughi M,

Banifazl M, Eslamifar A and Ramezani A. Frequency and Genotype of

Human Parvovirus B19 among Iranian Patients Infected With HIV. Journal of

Medical Virology 87(7):1124-9(2015)

• Sharif A, Sharif MR, Aghakhani A, Banifazl M, Hamkar R, Ghavami N,

Eslamifar A and Ramezani A. Prevalence of BK Viremia in Iranian

Hemodialysis and Peritoneal Dialysis Patients. Infectious Diseases 47(5):345-

348(2015)

• Ramezani A, Mohraz M, Banifazl M, Aghakhani A. Significance of hepatitis

E virus infection in HIV-infected patients: a challenging issue. Asian Pacific

Journal of Tropical Disease. 5(5):337-341(2015)

• Ramezani A, Kalantar E, Aghakhani A, Banifazl M, Foroughi M, Hosseini S,

Eslamifar A, Esmaeilzadeh A, Sadrpour P and Mohraz M. Lack of Association

between Interleukin-10 Gene Promoter Polymorphisms with HIV

Susceptibility and Progression to AIDS. Iranian Journal of Pathology 10 (2),

141 -148 (2015)

• Eslamifar A, Ramezani A, Azadmanesh A, Bidari-Zerehpoosh F, Banifazl M

and Aghakhani A. Assessment of the Association between Human

Papillomavirus Infection and Breast Carcinoma. Iranian Journal of Pathology

10(1):41-46(2015)

• Aghakhani A, Hamkar R, Ramezani A, Bidari-Zerehpoosh F, Sabeti S,

Ghavami N, Banifazl M, Rashidi N, Eslamifar A. Lack of Human

10

Papillomavirus DNA in Colon Adenocarcinama and Adenoma. Journal of

Cancer Research and Therapeutics 10(3):531-534(2014)

• Aghasadeghi MR, Banifazl M, Aghakhani A, Eslamifar A, Vahabpour R and

Ramezani A. No evidence for occult HBV infection in hepatitis B vaccine

non-responders. Iranian Journal of Microbiology 6(5):350-353(2014)

• Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl

M, Sofian M, Bahramali G, Hekmat S and Aghakhani A. Isolated Anti-HBc

and Occult HBV Infection in Dialysis Patients. Nephro-Urology Monthly 7(1):

e22674 (2014)

• Eslamifar A, Ramezani A, Banifazl M, Sofian M , Mahdaviani F, Yaghmaie F,

Aghakhani A. Immunity to diphtheria and tetanus among blood donors in

Arak, central province of Iran. Iranian Journal of Microbiology 6(3):190-193

(2014)

• Sofian M, Velayati AA, Aghakhani A, McFarland W, Farazi AA, Banifazl M,

Eslamifar A, Ramezani A. Comparison of two durations of triple drug therapy

in patients with uncomplicated brucellosis: a randomized controlled trial.

Scandinavian Journal of Infectious Diseases 46(8):573-577 (2014)

• Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland

W, Banifazl M, Mostafavi E, Eslamifar A and Sofian M. HCV, HBV, and

HIV seroprevalence, co-infections, and related behaviors among male

injection drug users in Arak, Iran. AIDS Care 26(9): 1122–1126 (2014)

• Ramezani A, Janbakhsh A, Gol-Mohammadi M, Banifazl M, Aghakhani A,

Eslamifar A, Pournasiri Z, ….. Serological Response to One Intradermal or

Intramuscular HBV Vaccine Booster Dose in HIV Infected Nonresponders to

Standard Vaccination. Perspective in Clinical Research. 5 (3):134-8(2014)

11

• Ramezani A, Eslamifar A, Banifazl M, Keyvani H, Razeghi E, Ahmadi F,

Amini M, Gachkar L, Bavand A, Aghakhani A. Occult HCV infection in

hemodialysis patients with elevated liver enzymes. Arak Medical University

Journal.16 (80): 34- 40 (2014)

• Bidari-Zerehpoosh F, Sharifi G, Zahedifard S, Soleimantabar H,

Ebrahimzadeh K and Aghakhani A. Bilateral Orbital Metastasis of Follicular

Thyroid Carcinoma: a Rare Case Report. Iranian Journal of Pathology 9(3),

229-233 (2014)

• Sofian M, …., Banifazl M, Aghakhani A, Eslamifar A, ……and Ramezani A.

Hematological Reference Values for Healthy Males in the Central Part of Iran.

Iranian Journal of Pathology 9(1):50-55 (2014)

• Ramezani A, Mohraz M, Banifazl M, Foroughi M, Eslamifar A, Aghakhani

A. Immune Response to Standard Hepatitis B Vaccination in HIV-Infected

Patients. Vaccine Research 1(2):12-15(2014)

• Sofian M , Aghakhani A , Mosayebi G , Ghaznavi-Rad E, Banifazl M,

Gachkar L, Eslamifar A and Ramezani A. Interlukine-8 Levels in Patients

with Acute Brucellosis and Its Relation with the Treatment. Iranian Journal of

Infectious Diseases and Tropical Medicine 19(66):1-4(2014)

• Sofian M, Aghakhani A, Banifazl M, Eslamifar A, Zolfaghari F, Sarmadian

H, Ramezani A. Differentiation of Brucella-Induced Epididymo-orchitis from

Nonspecific Epididymo-orchitis in an Endemic Area for Brucellosis. J Med

Microbiol Infec Dis.1 (1): 8-13 (2013)

• Ramezani A, Eslamifar A, Banifazl M and Aghakhani A. Importance of

Isolated Anti-HBc in Detection of Occult Hepatitis B Virus Infection in

Hemodialysis Patients. Therapeutic Apheresis and Dialysis 17(6):644 (2013)

12

• Sofian M, Safaeipour L, Aghakhani A, Sharif MR, Banifazl M, ….. Eslamifar

A, … Ramezani A. Screening of Family Members of Patients with Acute

Brucellosis in an Endemic Area. Iranian Journal of Microbiology 5(3):215-

219(2013)

• Ramezani A, …….., Eslamifar A , Mohraz M, Banifazl M, Bidari-Zerehpoosh

F, Yaghmaei F, McFarland W, …….., Mostafavi E and Aghakhani A.

Hepatitis E Virus Infection in Patients Infected with HIV in an Endemic Area

in Iran. International Journal of STD & AIDS 24(10) 769–774 (2013)

• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi SH,

Aghakhani A, Mashayekhi P. Seroprevalence of Hepatitis E Virus infection

among Volunteer Blood Donors in Central Province of Iran in 2012. Iranian

Journal of Microbiology 5(2):172-176(2013)

• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, ….,

Eslamifar A, Sadat M, Ramezani A . Frequency and Genotype of Hepatitis D

Virus Infection in Patients Infected with HIV and Hemodialysis Patients.

Hepatitis Monthly 13(5): e7481(2013)

• Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, ….., Eslamifar

A and Ramezani A. No Correlation between Interleukin-10 Gene Promoter

Polymorphisms and Hepatitis B Virus Infection Outcome. Hepatitis Monthly

13(5): e8803 (2013)

• Ramezani A, Banifazl M, Eslamifar A, Ahmadi F, Razeghi E and Aghakhani

A. Outcome of Hemodialysis Patients with Occult Hepatitis B Virus Infection

At 4 Year Follow-up. Journal of Gastrointestinal and Liver Diseases 22(1):12-

15(2013)

13

• Sofian M, Sheikholeslami M, Mahdaviani F, Aghakhani A, Banifaz M,

Eslamifar A, Sarmadian H, Deiri G, Ramezani A. Low Prevalence of Brucella

agglutinins in Blood Donors in Central Province of Iran. Iranian Journal of

Microbiology 5(1):24-27(2013)

• Ramezani A, Banifazl M, Aghakhani A. GB Virus C Overview: Insights into

Clinical Implication. Journal of Gastroenterology and Hepatology Research.

2(1): 343-349 (2013)

• Eslamifar A, Aghakhani A, Mohraz M, Banifazl M, Foroughi M, Ansari F,

Bolandghamat Z, Ramezani A. Seroepidemiology of Hepatitis E Virus

Infection in HIV Infected Patients. Iranian Journal of Infectious Diseases and

Tropical Medicine 17(59):33-36(2013)

• Sofian M, Aghakhani A, FaraziA, Banifazl M, Eslamifar A, Rashidi N,

Khadem-Sadegh A and Ramezani A. Serum Profile of T helper 1 and T helper

2 Cytokines in Hepatitis C virus Infected Patients. Hepatitis Monthly

12(12):e6156 (2012)

• Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi A, McFarland

W, Eslamifar A and Ramezani A. Viral hepatitis and HIV infection among

injection drug users in a central Iranian city. Journal of Addiction Medicine

6(4):292-6 (2012)

• Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F and Ramezani A. Viral

Hepatitis and HIV Infection in Hemodialysis Patients. Hepatitis Monthly

12(7): 463-464(2012)

• Ramezani A, Banifazl M, Eslamifar A, Sofian M and Aghakhani A. Occult

hepatitis B infection in different high risk patients. Hepatitis Monthly 12(7):

467-468(2012)

14

• Aghakhani A, Banifazl M, Velayati AA, Eslamifar A and Ramezani A.

Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for

Consideration. Therapeutic Apheresis and Dialysis 16(4):328-33(2012)

• Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A and Aghakhani

A. The Influence of Human Leukocyte Antigen and IL-10 Gene

Polymorphisms in Hepatitis B Virus Outcome. Hepatitis Monthly 12(5):320-

325(2012)

• Eslamifar A, Ramezani A, Banifazl M, Khadem-Sadegh A and Aghakhani A.

Seroprevalence of IgG Antibodies against Bordetella Pertussis in Different

Age Groups in Tehran. Iranian Journal of Pathology 7(3):171-176(2012)

• Soufian S , Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Boland-

Ghamat Z, Khadem-Sadegh A and Ramezani A. No evidence of the Th1 to

Th2 cytokine shift during the course of HIV infection. Iranian Journal of

Pathology 7(2):88-93(2012)

• Ramezani A, Aghakhani A, Banifazl M, …….., Khadem-Sadegh A and

Mohraz M. Frequency of Human T-Cell Lymphotropic Virus (HTLV) Type 1

and 2 Infection in HIV Infected Patients. Iranian Journal of Pathology 7(1):9-

13(2012)

• Eslamifar A, Ramezani A, Banifazl M and Aghakhani A. Tetanus and

diphtheria seroprevalence in patients infected with human immunodeficiency

virus. Iranian Journal of Pathology 7(1):27-31(2012)

• Soufian S, Mohraz M, Aghakhani A, Banifazl M, Froughi M, Eslamifar A,

Boland-Ghamat Z, Khadem-Sadegh A and Ramezani A. TH1/TH2 Cytokine

Levels in Human Immunodeficiency Virus Type 1 Infected Patient. Iranian

Journal of Infectious Diseases and Tropical Medicine 16(55):19-22(2012)

15

• Aghakhani A, Banifazl M, Izadi N, McFarland W, Sofian M, Khadem-

Sadegh A,….Eslamifar A, Ramezani A. Persistence of antibody to hepatitis B

surface antigen among vaccinated children in a low HBV endemic area. World

Journal of Pediatrics 7(4):358-60 (2011)

• Ramezani A, Banifazl M and Aghakhani A. Occult Hepatitis B Infection in

Chronic Hemodialysis Patients: Comparison of Results and Concepts.

Hepatitis Monthly 11(2):128-129 (2011)

• Aghakhani A, Hamkar R, Parvin M, …., Banifazl M, Eslamifar A, Izadi N,

Jam S and Ramezani A. The Role of Human Papillomavirus Infection in

Prostate Carcinoma. Scandinavian Journal of Infectious Diseases 43(1): 64-

69(2011)

• Ramezani A, Banifazl M, Mohraz M, Eslamifar A, Rasoolinejad M and

Aghakhani A. Occult Hepatitis B Virus Infection: A Major Concern in HIV-

Infected Patients. Hepatitis Monthly 11(1):7-10 (2011)

• Ramezani A, Banifazl M, Eslamifar A and Aghakhani A. Association

between Human Papillomavirus Infection and Risk of Prostate Cancer

(Review article). Iranian Journal of Pathology 6 (1): 3-7(2011)

• Kalantar E, Ramezani A, Hosseini S, Aghakhani A, Zarin Far N, Banifazl M

,………Eslamifar A and Sofian M. Interleukin-10 gene promoter

polymorphisms and hepatitis B virus infection outcome. Iranian Journal of


• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M……

Eslamifar A and Ramezani A. Frequency of hepatitis D virus infection in HIV

positive and hemodialysis patients. Iranian Journal of Infectious Diseases and


16

• Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong HM, McFarland

W, Banifazl M, Eslamifar A, ……. and Ramezani A. Assessing Subtype and

Drug-Resistance Associated Mutations among Antiretroviral-Treated HIV

Infected Patients. AIDS 24 (suppl 2):S85–S91 (2010)

• Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Khadem-Sadegh A and

Ramezani A. Occult Hepatitis B Virus Infection in Hemodialysis Patients with

Isolated Hepatitis B Core Antibody: A Multicentre Study. Therapeutic

Apheresis and Dialysis 14(3):349–353 (2010)

• Ramezani A, Banifazl M, EslamifarA and Aghakhani A. Serological pattern

of anti-HBc alone infers occult hepatitis B virus infection in high-risk

individuals in Iran. Journal of Infection in Developing Countries 4(10):658-

661 (2010)

• Ramezani A, Hamkar R, Aghakhani A, Lorestani SH, Banifazl M, Truong

HH, McFarland W, Foroughi M, Eslamifar A and Mohraz M. Subtype

Mutations and Related Drug-Resistance in Anti-Retroviral Treated HIV

Infected Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine15(50):1-7(2010)

• Mohraz M, Ramezani A, Rasoulinejad M, Izadi M, Haji-abdolbaghi M,

Banifazl M and Aghakhani A. Comparison of the Efficacy and Safety of

Tenofovir-Emtricitabine Compound to other Antiretroviral Combinations.

Iranian Journal of Infectious Diseases and Tropical Medicine15(49):7-

10(2010)

• Eslamifar A, Aghakhani A, Banifazl M, Gachkar L, Khadem-Sadegh A,

Ramezani A. Seroprevalence of Bordetella Pertussis Antibodies in Different

17

Age Groups. Iranian Journal of Infectious Diseases and Tropical Medicine

15(49):43-47(2010)

• Sofian M, Aghakhani A, Farazi AA, Banifazl M, …, Eslamifar A, Khadem-

Sadegh A, Izadi N and Ramezani A. Seroepidemiology of Hepatitis A Virus in

Children of Different Age Groups in Tehran, Iran: Implications for Health

Policy. Travel Medicine and Infectious Disease 8(3): 176-179 (2010)

• Hamkar R, Parvin M, Ghavami N, Ramezani A, …, Banifazl M, ….,

Eslamifar A and Aghakhani A. Involvement of Human Papillomavirus

Infection in Prostate Carcinoma. Iranian Journal of Infectious Diseases and


• Ramezani A, Azadmanesh K, Aghakhani A, Banifazl M, …. and Sofian M.

Frequency of occult hepatitis B virus infection in injection drug users. Iranian

Journal of Infectious Diseases and Tropical Medicine 15(48):39-42(2010)

• Sofian M, Aghakhani A,…Eslamifar A,…Ramezani A. Lack of occult

hepatitis B virus infection among blood donors with isolated anti-HBc living

in a HBV low prevalence region in Iran. International Journal of Infectious

Diseases 14(4):e308–e310 (2010)

• Sofian M. Moeeni L, ……. Aghakhani A, Banifazl M, Ramezani A.

Predictive value and cut of point of PPD in probable patients with pulmonary

tuberculosis. Iranian Journal of Infectious Diseases and Tropical Medicine

15(48):19-21(2010)

• Hamkar R, Aghakhani A, Soufian S, Banifazl M, ….., Eslamifar A and

Ramezani A. Surface Gene Mutations of Hepatitis B Virus among High Risk

Patients with Occult HBV Infection. Diagnostic Microbiology and Infectious

Disease 66(3):285-291(2010)

18

• Izadi N, Aghakhani A, Banifazl M , … Eslamifar A , .., Khadem-Sadegh A

and Ramezani A. Persistence of Anti-HBs antibody in HB Vaccinated

Children in a Low Endemic Area for HBV. Iranian Journal of Infectious

Diseases and Tropical Medicine 14(47):39-42(2010)

• Ramezani A, Hamkar R, Soufian S, Banifazl M ,……, Eslamifar A and

Aghakhani A. Genetic variability of the S gene of hepatitis B virus among

High Risk Patients with Occult HBV Infection. Iranian Journal of Infectious


• Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, ….Ramezani

A. Hepatitis B Virus Genotype in Iranian Patients with Hepatocellular

Carcinoma. International Journal of Infectious Diseases 13(6):685-89(2009)

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-

Sadegh A,…. Frequency of Isolated Hepatitis B Core Antibody in HIV-HCV

Coinfected Individuals. International Journal of STD & AIDS 20(5):336-

338(2009)

• Kariminia A, sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati M

and Ramezani A. Comparison of QuantiFERON TB-G test to TST for

detecting latent tuberculosis infection in a high-incidence area containing

BCG-vaccinated population. Journal of Evaluation in Clinical

Practice15(1):148–151(2009)

• Ramezani A, Eslamifar A, ……and Aghakhani A. Efficacy and Long-term

Immunogenicity of Hepatitis B Vaccine in Hemodialysis Patients.

International Journal of Clinical Practice 63(3): 394-97(2009)

19

• Ramezani A, Aghakhani A, Kalantar E, Eslamifar A, Banifazl M …. HLA-

A*3303 and *3301 Predispose Patients to Persistent Hepatitis B Infection.

Journal of Gastrointestinal and Liver Diseases 18(1):117-8(2009)

• Ramezani A, Sofian M, Banifazl M, …., Eslamifar A, Gachkar L, Khadem-

Sadegh A and Aghakhani A. Seroepidemiology of Hepatitis A Virus in

Children Residing in Tehran. Iranian Journal of Infectious Diseases and

Tropical Medicine 14(46):23-26 (2009)

• Velayati AA, Aghakhani A,....Eslamifar A....Ramezani A. Association of

polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with outcome of

hepatitis B virus infection. Iranian Journal of Infectious Diseases and Tropical

Medicine 14(46): 11-14 (2009)

• Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A ,….

Association between Hepatitis B Virus Infection Outcome and HLA-A and

DRB1 Genotyping in North Part of Iran. Iranian Journal of Pathology 4(2):71-

74(2009)

• Ramezani A, Banifazl M, Eslamifar A, Gachkar L, Aghakhani A. Prevalence

of hepatitis G virus in the sera of HIV infected patients with parenteral and

sexual exposure. Iranian Journal of Infectious Diseases and Tropical Medicine

14(45):27-29(2009)

• Ramezani A, Aghakhani A,…….. Eslamifar A, Sofian M. Occult hepatitis B

virus infection among blood donors in Arak. Iranian Journal of Infectious


• Ramezani A, Aghakhani A, Banifazl M, Eslamifar A,….Frequency of

isolated anti-HBc in HIV- HCV co-infected patients. Iranian Journal of


20

• Ramezani A, Mohraz M,….,Aghakhani A,…..Prevalence of dyslipidemia and

metabolic abnormalities in HIV-infected patients. Acta Medica Iranica

47(2):83-88(2009)

• Ramezani A, Banifazl M,……Eslamifar A…..and Aghakhani A. Occult

hepatitis B virus infection in hemodialysis patients. Iranian Journal of

Infectious Diseases and Tropical Medicine14(44):27-30(2009)

• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.

Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis B

Virus Infection. Iranian Journal of Pathology 4(2):80-84(2009)

• Ramezani A,…..Aghakhani A, Taeb J,… Influence of HLA class Ι and II on

the outcome of hepatitis B virus infection. Iranian Journal of Infectious

Diseases and Tropical Medicine13(43):1-4(2009)

• Ramezani A, ………Aghakhani A, Eslamifar A,…. Frequency of Occult

Hepatitis B Virus Infection in HIV Infected Patients. Iranian Journal of

Infectious Diseases and Tropical Medicine13(43):17-20(2009)

• Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M,

Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A. Frequency

and Genotype of GB Virus C among Iranian Patients Infected with HIV.

Journal of Medical Virology 80(11):1941-1946(2008)

• Azadmanesh K,….. Aghakhani A,……..Eslamifar A,….Ramezani A. Occult

Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B

Core Antibody. Intervirology 51(4):270-274 (2008)

• Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A,….Taeb J,

Aghakhani A… Association of Human Leukocyte Antigen polymorphism

21

with Outcomes to Hepatitis B Virus Infection. Journal of Gastroenterology

and Hepatology 23(11):1716-1721 (2008).

• Ramezani A, ... Vahabpour R,….Eslamifar A,….Aghakhani A,…Hekmat S.

Frequency of Hepatitis G Virus Infection among HIV Positive Subjects with

Parenteral and Sexual Exposure. Journal of Gastrointestinal and Liver

Diseases 17(3):269-72 (2008)

• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.

Frequency and Associated Factors of Proteinuria in Iranian HIV-Positive

Patients. International Journal of Infectious Diseases 12(5):490-494(2008)

• Ramezani A, ..,Hasanjani Roshan MR…….and Aghakhani A. Rate of

YMDD Motif Mutants in Lamivudine-Untreated Iranian Patients with Chronic

Hepatitis B Virus Infection. International Journal of Infectious Diseases.

12(3):252-55(2008)

• Ramezani A, Eslamifar A,, ……and Aghakhani A. Persistence of Hepatitis B

Vaccine Immunity in Hemodialysis Patients. Therapeutic Apheresis and

Dialysis 12(2):143-146 (2008).

• Sofian M., Aghakhani A., ….., Banifazl M, Eslamifar A. and Ramezani A.

Risk factors for human brucellosis in Iran: a case control study. International

Journal of Infectious Diseases. 12(2):157-61(2008).

• Ramezani A, Eslamifar A,…… Aghakhani A ,…. High Blood Mercury

Levels in Iranian Infants: cause for concern. Iranian Journal of Pathology

3(4):186-190 (2008)

• Aghakhani A, ……. Eslamifar A,…and Ramezani A. Asymptomatic

proteinuria in HIV-infected outpatients. Iranian Journal of Infectious Diseases

and Tropical Medicine 13(42):9-13(2008)

22

• Eslamifar A, Razzaghi-Abyaneh M,…… Ramezani A, Deljoodokht Z and

Aghakhani A. Frequency and Identification of Fungal Strains in Chronic

Rhinosinusitis Patients. Iranian Journal of Pathology 3(3):135-139(2008)

• Ramezani A, Aghakhani A ,… Eslamifar A,….Anemia prevalence and

related factors in a cohort of HIV- infected patients. Iranian Journal of

Pathology 3(3):125-128(2008)

• Ramezani A,…… Aghakhani A, Eslamifar A,….. Prevalence and Genotype

of Hepatitis G virus infection in HIV Positive Patients. Iranian Journal of


• Hamkar R, Zamani N, Ramezani A, Eslamifar A, ......and Aghakhani A.

Identification of Hepatitis B Virus Genotype in Iranian Hepatocellular

Carcinoma Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine13(41):23-29(2008)

• Eslamifar A, Ramezani A, Razzaghi Abyaneh M, Fallahian V, Mashayekhi P,

Hazrati M, Askari T, Fayaz A and Aghakhani A. Animal Bites in Tehran,

Iran. Archives of Iranian Medicine. 11(2):200-202(2008)

• Ramezani A, Aghakhani A, Eslamifar A….Taeb J,….. Long-Term Immunity

of Hepatitis B Vaccine in Patients Undergoing Hemodialysis. Iranian Journal

of Infectious Diseases and Tropical Medicine.13(40):21-24(2008)

• Kariminia A, Sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani A.

Evaluation of the blood gamma interferon assay for detection of latent

Tuberculosis infection: potential to replace the Mantoux skin test. Iranian

Journal of Infectious Diseases and Tropical Medicine.13(40):1-4(2008)

23

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

virus (HGV) Exposure in Dialysis Staff. Therapeutic Apheresis and Dialysis.

11(5):370-374(2007)

• Eslamifar A, Aghakhani A, Hamkar R, Ramezani A,..... Frequency of Human

Papillomavirus Infection in Iranian Esophageal Squamous Cell Carcinoma

patients. Scandinavian Journal of Infectious Disease 39(1):58-62(2007).

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

Virus Exposure in Dialysis Patients. International Urology and Nephrology

39(4): 1257-1263 (2007)

• Jam S, Sabzevari D, Aghakhani A, Eslamifar A, Banifazl M and Ramezani A.

Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas

aeruginosa in a pediatric hospital. Iranian Journal of Pathology 2(4):144-

48(2007)

• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.

Metabolic abnormalities in HIV-positive patients receiving highly active

antiretroviral therapy. Iranian Journal of Pathology 2(4):154-58(2007)

• Soofian M,…. Eslamifar A, Aghakhani A, Ramezani A. Eosinophilic

gastroenteritis: A case report. Iranian Journal of Infectious Disease and

Tropical Medicine .12(38):63-6(2007)

• Ramezani A, Eslamifar A, Aghakhani A,…..Blood mercury levels in infants

receiving vaccines containing Thimerosal. Iranian Journal of Infectious

Disease and Tropical Medicine. 12(38):17-20(2007)

• Eslamifar A, Tirgari F, Hamkar R, Ramezani A …… Deljoodokht Z and

Aghakhani A. Role of the Human Papillomavirus infection in Esophageal

Squamous Cell Carcinoma. Iranian Journal of Pathology. 2(1):11-16(2007)

24

• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in

chronic B hepatitis. Iranian Journal of Infectious Diseases and Tropical

Medicine. 12(37): 1-6(2007)

• Eslamifar A, Aghakhani A, Ramezani A,... Detection of Hepatitis G Virus

Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of Infectious

Diseases and Tropical Medicine. 11(35): 73-79 (2007)

• Eslamifar A, Aghakhani A , Hamkar R, Ramezani A, Tirgari F, Frootan H,

…., Taeb J. Detection of High Risk Human Papillomaviruses in Esophageal

Squamous Cell Carcinoma by PCR and DNA Sequencing. Iranian Journal of

Infectious Disease and Tropical Medicine. 11(33): 1-5(2006)

• Mirhassani moghaddam SJ, Daneshmand MA, Aghakhani A....... p53, and

Rb Genes Expression Changes in Esophageal Squamous Cell Carcinoma.

Research in Medical Sciences 7(4) (2002)

Books:

1. New edition of "Guide to antimicrobial therapy and vaccination" .Chief

Editor: Iranian Society for Infectious Diseases and Tropical Medicine

publication (2013-2016)

2. New edition of "Guide to antimicrobial therapy and vaccination". Pousheh

Publication, Tehran, Iran (2012)


Editor: Iranian society for infectious diseases and tropical medicine

publication (2010)

4. Risk factors for human brucellosis in Iran (In English & German). VDM

Verlag publication (2009).

25

5. Nanotechnology and Medicine. Hayyan press. Tehran, Iran (2009)


Editor: Iranian society for infectious diseases and tropical medicine

publication (2009)

7. New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian

society for infectious diseases and tropical medicine publication (2008)

8. New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian

society for infectious diseases and tropical medicine publication (2007)

9. Application of Nanotechnology in medicine, Sharh Publication, Tehran

(2005)

Presentations:

• Ramezani A, Aghakhani A, Banifazl M, Tabatabaei Yazdi SM, Bavand A,

Kazemimanesh M, Larijani MS, Zadsar M. Seroprevalence and Molecular

Epidemiology of Parvovirus B19 among Iranian Blood Donors. 25th

Iranian

congress on infectious diseases and tropical medicine, Tehran, Iran (2016)

• Ramezani A, Mamishi S, Sabeti S, Bidari-Zerehpoosh F, Banifazl M, Bavand

A and Aghakhani A. Gender and Age-specific Seroprevalence of Human

Papillomavirus 16 and 18 in General Population in Tehran. 25th

Iranian


• Mohraz M, Aghakhani A, Banifazl M, Janbakhsh A, Moayedi-Nia S, Bavand

A and Ramezani A. No Role of Herpes Simplex Virus Type 2 (HSV-2)

Infection on HIV Progression in Naïve HIV Patients. 25th

Iranian congress on

infectious diseases and tropical medicine, Tehran, Iran (2016)

26

• Ramezani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R,

Foroughi M and Aghakhani A. Occult Hepatitis B Virus Infection and S Gene

Escape Mutants in HIV Infected Patients after HBV Vaccination. 25th

Iranian


• Aghasadeghi MR, Aghakhani A, Mamishi S, Nabavi M, SoleymaniS, Haghi

Ashtiani MT, Banifazl M, Vahabpour R, Motevalli F, Ramezani A.

Seroprevalence of HBV infection and vaccine escape mutants: 22 years after

infant HBV vaccination in Iran. 26th

European Congress of Clinical

Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands

(2016)

• Sofian M, Banifazl M, Ziai M, Aghakhani A, Farazi A, Ramezani A. Intra-

familial transmission of hepatitis B virus infection in Arak City. 26th

European

Congress of Clinical Microbiology and Infectious Diseases (ECCMID),

Amsterdam, Netherlands (2016)

• Ramezani A, Mohraz M, Azadmanesh K, Vahabpour R, Kazemimanesh M,

Banifazl M, Akhgari S, Bavand A and Aghakhani A. Molecular

epidemiology of BK virus in Iranian HIV-infected patients. 26th

European


Amsterdam, Netherlands (2016)

• Ramezani A, Sharif A, Sharif MR, Aghakhani A, Hamkar R, Ghavami N,

Eslamifar A and Banifazl M. BK Viremia in patients with chronic renal

disease undergoing Hemodialysis and Peritoneal Dialysis. 25th

European


Copenhagen, Denmark (2015)

27

• Ramezani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R,

Foroughi M, Eslamifar A and Aghakhani A. Occult Hepatitis B Virus

Infection in HIV Infected Patients after HBV Vaccination. 25th

European


Copenhagen, Denmark (2015)

• Sofian M, Ramezani A, Banifazl M, Eslamifar A, Cherei S, Cherei A and

Aghakhani A. Interlukine-17 and TGF-β Levels in Patients with Acute

Brucellosis and Its relation with Treatment. 25th

European Congress of

Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen,

Denmark (2015)

• Ramezani A, Azadmanesh K, Kazemimanesh M, Aghakhani A, Foroughi M,

Banifazl M, Eslamifar A and Mohraz M. Molecular Epidemiology of Human

Parvovirus B19 in a Cohort of HIV Infected Patients. 25th

European Congress

of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen,

Denmark (2015)

• Eslamifar A, Ramezani A, Ossareh S, Banifazl M, Keyvani H and Aghakhani

A. No Evidence of Occult Hepatitis C Virus Infection among Renal Transplant

Candidates. 25th

European Congress of Clinical Microbiology and Infectious

Diseases (ECCMID), Copenhagen, Denmark (2015)

• Aghasadeghi MR, Aghakhani A, Mamishi S, Nabavi M, … Banifazl M,

Motevalli F and Ramezani A. Seroprevalence of HBV Infection and Vaccine

Escape Mutants: 22 years after Infant HBV vaccination in Iran. 24th

Iranian


• Sofian M, Ramezani A, Imani H, Banifazl M, Farazi A and Aghakhani A.

Distribution of Hepatitis C Virus Genotypes in Arak City, Central Province of

28

Iran. 24th

Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2015)

• Sofian M, Banifazl M, Ziai M, Aghakhani A, Farazi A and Ramezani A.

Intra-familial Transmission of Hepatitis B Virus Infection in Arak City. 24th

Iranian congress on infectious diseases and tropical medicine, Tehran, Iran

(2015)

• Ramezani A, Mohraz M, Azadmanesh K, Moayedi-Nia S, Kazemimanesh M,

Banifazl M and Aghakhani A. Persistence of Parvovirus B19 Viremia in

Iranian HIV Infected Patients. 24th

Iranian congress on infectious diseases and

tropical medicine, Tehran, Iran (2015)

• Sharif A, Sharif MR, Aghakhani A, Hamkar R, Ghavami N, Eslamifar A,

Banifazl M and Ramezani A. Low BKV Replication in Chronic Renal

Diseases Patients Undergoing Hemodialysis and Peritoneal Dialysis.23rd


(2015)

• Eslamifar A, Ramezani A, Ossareh S, Banifazl M and Aghakhani A. Lack of

BK Viremia in Renal Transplant Candidates.23rd

Iranian congress on


• Ramezani A, Azadmanesh K, Aghakhani A, Kazemimanesh M, Foroughi M,

Banifazl M, Eslamifar A and Mohraz M. No evidence of Human Herpesvirus

8 (HHV-8) Viremia among HIV Infected Patients.23rd

Iranian congress on


• Sofian M, Ramezani, A, Banifazl M, Eslamifar A, Cherei S, Cherei A and

Aghakhani A. Interlukine-17 and TGF-β Levels in Acute Brucellosis Patients

29

Before and After Treatment.23rd



• Eslamifar A, Ramezani A, Ossareh S, Banifazl M, Keyvani H and Aghakhani

A. Occult Hepatitis C Virus Infection in Candidates of Renal Transplantation.

23rd

Iranian congress on infectious diseases and tropical medicine, Tehran,

Iran (2015)

• Ramezani A, Azadmanesh K, Aghakhani A, Kazemimanesh M, Foroughi M,

Banifazl M, Eslamifar A and Mohraz M. Frequency and subtypes of Human

Parvovirus B19 in HIV Infected Patients.23rd

Iranian congress on infectious

diseases and tropical medicine, Tehran, Iran (2015)

• Sofian M, Aghakhani A, Farazi AA, Banifazl M, Ramezani A. A randomized

clinical trial study comparing a triple drug regimen in two different durations

for treatment of patients with uncomplicated Brucellosis. 24th

European

Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain

(2014)

• Ramezani A, Banifazl M , Eslamifar A, Razeghi E, Ahmadi F, Amini M,

Keyvani H and Aghakhani A. Occult Hepatitis C Virus Infection among

Iranian Hemodialysis Patients. 24th

European Congress of Clinical

Microbiology and Infectious Diseases, Barcelona, Spain (2014)

• Sofian M, Aghakhani A , Farazi A, Banifazl M, Ramezani A.A Randomized

Clinical Trial Comparing two Different Durations of Brucellosis Treatment.

22nd


Iran (2014)

• Ramezani A, Eslamifar A, Keyvani H, Banifazl M, Razeghi E, Ahmadi F and

Aghakhani A. No Evidence of Occult HCV infection in Hemodialysis

30

Patients with Elevated Liver Enzymes. 22nd

Iranian congress on infectious

diseases and tropical medicine, Tehran, Iran (2014)

• Aghakhani A, Hamkar R, Eslamifar A, Bidari-Zerehpoosh F, Sabeti S,

Ghavami N, Banifazl M , Ramezani A. No Evidence of Human

Papillomavirus Infection in the Etiology of Colon Adenocarcinamas and

Adenomas. 15th

Annual Congress of Iranian Society of Pathology, Tehran,

Iran (2013)

• Sofian M, Shams M, Aghakhani A, Banifazl M, Eslamifar A, ….. and

Ramezani A. Hematological Reference Ranges for Healthy Adult Males in the

Central province of Iran.15th

Annual Congress of Iranian Society of

Pathology, Tehran, Iran (2013)

• Eslamifar A, Ramezani A, Banifazl M, ….. and Aghakhani A. Immunity to

Diphtheria and Tetanus among Blood Donors in a Central Iranian City. 15th

Annual Congress of Iranian Society of Pathology, Tehran, Iran (2013)

• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Mashayekhi P

and Aghakhani A. Seroepidemiology of Hepatitis E Virus infection in Blood

Donors of Central Province of Iran. 15th

Annual Congress of Iranian Society

of Pathology, Tehran, Iran (2013)

• Sofian M, Janbakhsh A, Aghakhani A, Banifazl M , Gol-Mohammadi M,

Eslamifar A, ……and Ramezani A. Immunogenicity of one Intradermal or

Intramuscular Booster Vaccination Dose in HIV Infected individuals who

failed to Standard Vaccination. 15th

Annual Congress of Iranian Society of

Pathology, Tehran, Iran (2013)

• Sofian M, Aghakhani A, Amir-Moezzi R , Zarinfar N, Banifazl M, Eslamifar

A and Ramezani A. Prevalence of HIV, HCV and HBV Infections and

31

Associated Risk Factors among Injecting Drug Users in Arak City. 21st Iranian


• Sofian M, Sheikholeslami M, Sarmadian H, Mahdaviani F, Aghakhani A,

Eslamifar A, Deiri GH, Ramezani A. Seroprevalence of Brucellosis

Antibodies in Blood Donors in Central Province of Iran. 21st Iranian congress

on infectious diseases and tropical medicine, Tehran, Iran (2013)

• Ramezani A, Mohraz M, Eslamifar A, Banifazl M, ….. and Aghakhani A.

Hepatitis E virus co-infection in HIV infected patients. 21st Iranian congress


• Aghakhani A, Aghasadeghi MR, Banifazl M, Eslamifar A, …..and Ramezani

A. Occult Hepatitis B Virus Infection in Hemodialysis Patients. 21st Iranian


• Sofian M, Safaeipour L, Aghakhani A, Banifazl M, Eslamifar A, Farazi A,

Didgar F, Ramezani A. Importance of Family Members Screening of Cases

with Acute Brucellosis. 21st Iranian congress on infectious diseases and


• Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Aghakhani A. Follow up

of Hemodialysis Patients with Occult Hepatitis B Virus Infection. 21st Iranian


• Ramezani A, Aghasadeghi M, Bahramali G, Aghakhani A, Banifazl M, …….

Eslamifar A, Siadat S, Mohraz M. Frequency of hepatitis D virus infection in

HIV-positive and haemodialysis patients in Iran. 22nd


Clinical Microbiology and Infectious Diseases (ECCMID), London, UK

(2012)

32

• Soufian S, Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.

Reduction in interleukin-2 serum levels but lack of evidence of the Th1 to Th2

cytokine shift during the course of HIV infection. 22nd


Clinical Microbiology and Infectious Diseases (ECCMID), London, UK

(2012)

• Sofian M, Banifazl M, Aghakhani A, ….. Ramezani A. Evaluation of

interleukin-10 gene promoter polymorphisms and hepatitis B virus infection

outcome. 22nd

European Congress of Clinical Microbiology and Infectious

Diseases (ECCMID), London, UK (2012)

• Ramezani A, Sofian M, Aghakhani A, Farazi A, Banifazl M,. Eslamifar A,

Velayati A. Serum profile of T helper 1 and T helper 2 cytokines in HCV-

infected patients. 22nd

European Congress of Clinical Microbiology and

Infectious Diseases (ECCMID), London, UK (2012)

• Sofian M , Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, …..

Comparison of Brucella Induced epididymo-orchitis with Nonspecific

Epididymo-orchitis in an Endemic Area for Brucellosis. 20th

Iranian congress


• Ramezani A, Sofian M, Aghakhani A ,…. Banifazl M, Eslamifar A, …..

Serum Profile of T helper 1 and T helper 2 Cytokines in HCV Infected

Patients. 20th


Tehran, Iran (2011)

• Ramezani A, Aghasadeghi MR, Bahramali G, Aghakhani A, Banifazl M,

…..Eslamifar A, ….. Frequency of hepatitis D virus infection in HIV positive

and hemodialysis patients in Iran. 20th

Iranian congress on infectious diseases

and tropical medicine, Tehran, Iran (2011)

33

• Ramezani A, Aghakhani A, Banifazl M, Forough M, Eslamifar A and

Mohraz M. Seroprevalence of Human T-Cell Leukemia Virus Type 1 (HTLV-

1) and HTLV-2 Infection in HIV Infected Patients. 20th

Iranian congress on


• Ramezani A, Sofian M, Banifazl M, Aghakhani A,….. Eslamifar A, …..

Evaluation of Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B

Virus Infection Outcome. 20th



• Eslamifar A, Ramezani A, Mohraz M, Banifazl M, Forough M and

Aghakhani A. Tetanus and diphtheria seroprevalence in HIV infected

patients. 20th


Tehran, Iran (2011)

• Panel about Hepatitis.10th

midyear conference of infectious diseases. Babolsar,

Iran (2011)

• Ramezani A, ….., Aghakhani A, Soufian S, Eslamifar A and Banifazl M.

Mutations in the S gene region of hepatitis B virus in High Risk Patients with

Occult HBV Infection. 20th ECCMID, Vienna, Austria (2010)

• Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A and Ramezani A.

Distribution of pertussis antibodies among Iranian children of different age

groups. 20th ECCMID, Vienna, Austria (2010)

• Ramezani A, Hamkar R, Aghakhani A, Banifazl M, ….. Prevalence of

Secondary Resistant Mutations to Antiretroviral Drugs in Iranian HIV Infected

Patients. 20th ECCMID, Vienna, Austria (2010)

34

• Ramezani A, Aghakhani A, Sofian M, …., Khadem-Sadegh A and Banifazl

M. Seroepidemiology of Hepatitis A Virus in Iranian Children. 20th

ECCMID, Vienna, Austria (2010)

• Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M and Ramezani

A. The Role of Human Papillomavirus Infection in Prostate Carcinoma. 14th

ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of

isolated antibody to hepatitis B core antigen in HIV- HCV coinfected

individuals. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Association of

polymorphism of HLA-DRB1 13 and HLA-A 33 alleles with outcome of

hepatitis B virus infection. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. No evidence of

occult hepatitis B virus infection among anti-HBc-positive blood donors in an

area of low endemicity for HBV. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of occult

hepatitis B virus infection in HIV infected patients. 14th ICID - Miami,

Florida, USA (2010)

• Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. The

epidemiology of tuberculosis in Arak city, Central province of Iran from 1997-

2007. 14th ICID - Miami, Florida, USA (2010)

• Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Anti-HBs titers in

vaccinated children and adolescents: Implication for booster administration.

14th ICID - Miami, Florida, USA (2010)

35

• Ramezani A, Banifazl M,…….. Eslamifar A,… Aghakhani A. Prevalence of

Occult Hepatitis B Infection in Iranian Injection Drug Users. 14th ICID -

Miami, Florida, USA (2010)

• Sofian M,….. Aghakhani A, Banifazl M, Ramezani A. Predictive value and

cut off point of PPD in probable patients with pulmonary tuberculosis. 14th

ICID - Miami, Florida, USA (2010)

• Sofian M,….. Ramezani A,…. Aghakhani A, Banifazl M. Prevalence of

isolated hepatitis B core antibody among injection drug users in central

province of Iran. 14th ICID - Miami, Florida, USA (2010)

• Eslamifar A, Ramezani A, Banifazl M, Bidari F, Moradi A and Aghakhani A.

Association of Human Papillomavirus and Breast Carcinoma.19th Iranian


• Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Banifazl M. Occult and

chronic hepatitis B, hepatitis C, and HIV infections and co-infections among

injection drug users. 19th Iranian congress on infectious diseases and tropical

medicine, Tehran, Iran (2010)

• Panel about Hepatitis. 9th

midyear conference of infectious diseases. Kish, Iran

(2010)

• Aghakhani A, Hamkar R, …Eslamifar A,….Ramezani A. Identification of

hepatitis B virus genotype in patients with hepatocellular carcinoma in

Iran.19th ECCMID, Helsinki, Finland (2009)

• Ramezani A, …, Aghakhani A, ….. Eslamifar A, …. Genotype

characterization of hepatitis G virus isolates from Iranian patients infected

with human immunodeficiency virus. 19th ECCMID, Helsinki, Finland(2009)

36

• Ramezani A, Aghakhani A, ….., Eslamifar A, Khadem-Sadegh A, Banifazl

M. Occult hepatitis B virus infection in “anti-HBc alone” haemodialysis

patients. 19th ECCMID, Helsinki, Finland(2009)

• Sofian M, Ramezani A, ….. Aghakhani A, Eshrati B, Eslamifar A, Banifazl

M. Predictive value of purified protein derivative in pulmonary tuberculosis in

a high BCG-vaccinated population. 19th ECCMID, Helsinki, Finland(2009)



Virus Infection. The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran

(2009)

• Aghakhani A, ….., Eslamifar A, Khadem-Sadegh A and Ramezani A.

Frequency of isolated antibody to hepatitis B core antigen in HIV- HCV

coinfected individuals. The 3rd

Annual Iranian Congress on HIV/AIDS.

Tehran, Iran (2009)

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar

A,……Hamkar R. Frequency of Occult Hepatitis B Virus Infection and its

Surface Mutants in HIV Positive Patients. The 3rd

Annual Iranian Congress on

HIV/AIDS. Tehran, Iran (2009)

• Hamkar R, Ramezani A, Aghakhani A, Banifazl M, …. Frequency of drug

resistance mutations in HIV-positive patients receiving antiretroviral therapy.

The 3rd

Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009)

• Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Izadi N, Banifazl M.

Occult hepatitis B virus infection in blood donors with isolated anti-HBc. 18th


(2009)

37

• Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M, Ramezani A.

Association of Human Papillomavirus with Prostate Cancer. 18th

Iranian


• Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A, Ramezani A.

Seroepidemiology of pertussis antibodies among children of different age

groups. 18th


Tehran, Iran (2009)

• Ramezani A, Mohraz M, Hamkar R, Aghakhani A, Eslamifar A, Soufian S,

Banifazl M. Hepatitis B virus Surface Gene Mutations in High Risk Patients

with Occult HBV Infection. 18th



• Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl

M. Age specific seroprevalence of hepatitis A antibody: Implications for

health policy. 18th

Iranian congress on infectious diseases and tropical


• Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl

M. Seroprevalence of hepatitis B surface antibody in children subjected to the

Expanded Programme on Immunization (EPI). 18th

Iranian congress on


• Panel about chronic hepatitis B. 8th

midyear conference of infectious diseases.

Babolsar, Iran (2009)

• Ramezani A, …., Vahabpour R, …, Eslamifar A, Mahboudi F, Aghakhani A,

Edalat R, Hekmat S. Hepatitis G virus infection in patients infected with the

human immunodeficiency virus. 13th ICID - Kuala Lumpur, Malaysia (2008)

38

• Ramezani A,…… Eslamifar A,…..Taeb J, Aghakhani A….. Association

between HLA-A, B, DRB1 alleles and susceptibility or resistance to chronic

hepatitis B. 13th ICID - Kuala Lumpur, Malaysia (2008)

• Ramezani A, ……. Aghakhani A, Eslamifar A…. Prevalence of Metabolic

abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral

Therapy and antiretroviral-naive patients. 13th ICID - Kuala Lumpur,

Malaysia (2008)

• Ramezani A, Eslamifar A, ….. and Aghakhani A. Long term Immune

response to hepatitis B vaccine in hemodialysis patients. 13th ICID - Kuala

Lumpur, Malaysia (2008)

• Ramezani A,… Eslamifar A,……and Aghakhani A. Comparison of IFN-

gamma assay and Tuberculin Skin Test for detecting latent tuberculosis

infection in BCG-vaccinated population. 13th ICID - Kuala Lumpur, Malaysia

(2008)

• Eslamifar A, Aghakhani A, Ramezani A,……. The role of fungi in the

etiology of chronic rhinosinusitis. 12th

International Congress of Mycology.

Istanbul, Turkey (2008)

• Aghakhani A, Hamkar R,…….Eslamifar A,…..Ramezani A. Genotype

Characterization of Hepatitis B Virus Isolates from Iranian Patients with

Hepatocellular Carcinoma . 10th

annual congress of pathology and 4th

annual

congress of Iranian cancer association, Tehran, Iran (2008)

• Eslamifar A,…. Ramezani A,….and Aghakhani A. Frequency of Fungi and

Eosinophilic Granulocytes in Chronic Rhinosinusitis . 10th

annual congress of

pathology and 4th

annual congress of Iranian cancer association, Tehran, Iran

(2008)

39



Virus Infection. 17th



• Ramezani A, ….. Aghakhani A,… Eslamifar A and Velayati AA. Genotype

characterization of hepatitis G virus isolates from Iranian patients infected

with human immunodeficiency virus (HIV). 17th

Iranian congress on


• Ramezani A, ….. Aghakhani A, Banifazl M, Eslamifar A, ….. Frequency of

isolated antibody to hepatitis B core antigen in HIV- HCV coinfected

individuals. 17th


Tehran, Iran (2008)

• Ramezani A, Aghakhani A,…. Eslamifar A,… Association of polymorphism

of HLA-DRB1*13 and HLA-A *33 alleles with outcome of hepatitis B virus

infection. 17th


Tehran, Iran (2008)

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, …. Frequency of occult

hepatitis B virus infection in HIV infected patients. 17th

Iranian congress on


• Ramezani A, Aghakhani A, Eslamifar A, Khadem-Sadegh A, Banifazl M.

Occult hepatitis B virus infection in "anti-HBc alone" hemodialysis patients.

17th


Iran (2008)

• Panel about Diagnosis and treatment of chronic Brucellosis and Brucellosis

relapse. 7th

midyear conference of infectious diseases. Isfahan, Iran (2008)

40

• Soofian M, Ramezani A, ......, Aghakhani A, Eslamifar A. Risk factors for

human brucellosis in Iran: a case control study. ECCMID-ICC , Munich,

Germany(2007)

• Ramezani A, …, Banifazl M, Aghakhani A…. Frequency of proteinuria

among HIV-infected patients .ECCMID-ICC, Munich, Germany (2007).

• Eslamifar A, Aghakhani A, Ramezani A,…… Prevalence of hepatitis G

exposure in patients on chronic dialysis. 21st European Congress of Pathology,

Istanbul, Turkey (2007)

• Kariminia A, Sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati M

and Ramezani A. Performance of QuantiFERON TB-G Test for detecting

latent tuberculosis infection in BCG-vaccinated population. 16th

Iranian


• Ramezani A, Eslamifar A......and Aghakhani A. Persistence of Hepatitis B

Vaccine Immunity in Hemodialysis Patients.16th

Iranian congress on


• Ramezani A, ….. Aghakhani A, Eslamifar A,... Frequency of hepatitis B and

hepatitis C virus infections in HIV infected subjects.16th

Iranian congress on


• Ramezani A, .... Aghakhani A, Eslamifar A,... Impact of antiretroviral

treatment on lipid profile in HIV infected patients. 16th

Iranian congress on


• Ramezani A, Mohraz M,.... Aghakhani A, Eslamifar A,... Anemia in HIV-

infected patients receiving highly active antiretroviral therapy. 16th

Iranian


41

• Ramezani A. Hasanjani Roshan MR,... Eslamifar A..... Taeb J, Aghakhani

A.... Influence of HLA class І and II alleles on the outcome of hepatitis B

virus infection. 16th



• Ramezani A,........,Eslamifar A and Aghakhani A. Detection of YMDD

mutation in Iranian chronic hepatitis B patients before lamivudine treatment.

9th

annual congress of pathology and 3rd

annual congress of Iranian cancer

association, Tehran, Iran (2007)

• Mohraz M, Ramezani A, Banifazl M,...and Aghakhani A. Frequency and

Associated Factors of Proteinuria in HIV-Positive Patients .The first annual

AIDS research congress of Iran. Tehran, Iran (2007)

• Panel about Hepatitis in 6th

midyear conference of infectious diseases.

Babolsar 16-19 Oct (2007)

• Esalamifar A, Aghakhani A, Hamkar R, Ramezani A....Frequency of Human

Papillomavirus Infection in Esophageal Squamous Cell Carcinoma of Iranian

patients. 12th

International Congress on Infectious Diseases, Lisbon, Portugal

(2006)

• Eslamifar A, Ramezani A....and Aghakhani A. Hepatitis G virus exposure in

dialysis patients. 8th

annual congress of pathology and 2nd

annual congress of

Iranian cancer association, Tehran, Iran (2006)

• Eslamifar A , Hamkar R, Ramezani A....and Aghakhani A. Role of human

papillomavirus infection in esophageal carcinoma.8th

annual congress of

pathology and 2nd

annual congress of Iranian cancer association, Tehran, Iran

(2006)

42

• Eslamifar A, Aghakhani A, Ramezani A, …. Epidemiology of Animal Bites

in Tehran.15th


Tehran, Iran (2006)

• Eslamifar A, Hamkar R, Ramezani ……and Aghakhani A. Hepatitis G virus

(HGV) Exposure in Dialysis Staff. 15th

Iranian congress on infectious diseases

and tropical medicine, Tehran, Iran (2006)

• Ramezani A , ………, Eslamifar A and Aghakhani A .YMDD mutants in

patients with chronic hepatitis B before treatment are not selected by

lamivudine.15th


Tehran, Iran (2006)

• Eslamifar A, Hamkar R, Ramezani A ……and Aghakhani A. Exposure to

Hepatitis GB Virus in Patients on Maintenance Hemodialysis. 15th

Iranian


• Panel about Hepatitis in 5th

midyear conference of infectious diseases

Babolsar 1-2 Nov (2006)

• Moghaddam S, Daneshmand M, Aghakhani A, Edrissian M, Zali M. P53,

cyclin D1 and Rb genes expression changes in esophageal squamous cell

carcinoma in Iran. Digestive Disease Week and the 104th Annual Meeting of

the American Gastroenterological Association. Orlando, FL, USA (2003)

• Lecture about Diabetes Mellitus: Congress of Pathology (2003)

• Lecture about Gout & Gouty Arthritis: Congress of Pathology (2002)

• Mirhassani-Moghaddam SJ,.....Aghakhani A....... p53, cyclin D1 and Rb

Genes Expression Changes in Esophageal Squamous Cell Carcinoma in Iran,

43

First Iranian Congress on from Bed to Bench in Gastroenterology & Liver

Diseases(2002)

• Lecture about Macroglobulinemia and Heavy Chain Diseases: Congress of

Pathology (2001& 2003)

Thesis:

• Designing formualtion of Betulinic acid and Amphotericin B encapsulated

into dendrimer and chitosan nanocarriers and evaluation their therapeutic

effects on Leishmania Major lesion in mouse model

• Molecular epidemiology of Herpes virus type 8 (HHV-8) in HIV infected

patients

• Frequency and genotype of Human Parvovirus B19 in HIV infected patients

• Frequency of occult Hepatitis B infection and S gene mutations in dialysis

patients

• Frequency of human papillomavirus infection in colon adenocarcinoma and

adenomatous polyps

• Frequency of human papillomavirus infection in prostate carcinoma and

benign prostatic hyperplasia in Tehran

• Hepatitis B virus genotyping in hepatocellular carcinoma in Iranian patients

• Comparison of GMS and Chitinase staining in clinical diagnosis of fungal

chronic rhinosinusitis

• Histopathology and immunohistochemical study of primary tumors of the

pituitary in Loghman Hakim hospital from 1386 to 1392

education: positionsen.pasteur.ac.ir/userfiles/file/cv/clinical research epidemiology... · occult...

Documents